Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

Semaglutide is a 3rd generation GLP-1 agonist, though. We're 20 years in on GLP-1s at this point.


Consider applying for YC's Summer 2026 batch! Applications are open till May 4

Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: